These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7420061)

  • 1. Isolation and preliminary characterization of Semliki Forest virus mutants with altered virulence.
    Barrett PN; Sheahan BJ; Atkins GJ
    J Gen Virol; 1980 Jul; 49(1):141-7. PubMed ID: 7420061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures.
    Gates MC; Sheahan BJ; O'Sullivan MA; Atkins GJ
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2365-73. PubMed ID: 2997371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
    Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles.
    Atkinson T; Barrett AD; Mackenzie A; Dimmock NJ
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1189-94. PubMed ID: 3011976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice.
    Glasgow GM; Sheahan BJ; Atkins GJ; Wahlberg JM; Salminen A; Liljeström P
    Virology; 1991 Dec; 185(2):741-8. PubMed ID: 1660202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semliki forest virus neurovirulence mutants have altered cytopathogenicity for central nervous system cells.
    Atkins GJ; Sheahan BJ
    Infect Immun; 1982 Apr; 36(1):333-41. PubMed ID: 6176545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and preliminary characterization of Semliki Forest virus mutants with altered pathogenicity for mouse embryos.
    Hearne AM; O'Sullivan MA; Atkins GJ
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():107-13. PubMed ID: 3027238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelination in mice resulting from infection with a mutant of Semliki Forest virus.
    Sheahan BJ; Barrett PN; Atkins GJ
    Acta Neuropathol; 1981; 53(2):129-36. PubMed ID: 6259872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
    Smyth JM; Sheahan BJ; Atkins GJ
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis.
    Amor S; Scallan MF; Morris MM; Dyson H; Fazakerley JK
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():281-91. PubMed ID: 8627232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide.
    Bradish CJ; Allner K; Fitzgeorge R
    J Gen Virol; 1975 Aug; 28(2):225-37. PubMed ID: 1176966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent and strain-related differences of virulence of Semliki Forest virus in mice.
    Fleming P
    J Gen Virol; 1977 Oct; 37(1):93-105. PubMed ID: 915485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Semliki Forest virus E2 gene as a virulence determinant.
    Santagati MG; Määttä JA; Itäranta PV; Salmi AA; Hinkkanen AE
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():47-52. PubMed ID: 7844541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of demyelination by a temperature-sensitive mutant of the coronavirus MHV-A59 is associated with restriction of viral replication in the brain.
    Koolen MJ; Love S; Wouda W; Calafat J; Horzinek MC; van der Zeijst BA
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():703-14. PubMed ID: 3029299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lethal respiratory infection of rabbits with a strain of Semliki Forest virus (SFV).
    Boulter EA; Zlotnik I; Maber HB
    Br J Exp Pathol; 1971 Dec; 52(6):638-45. PubMed ID: 5135535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of gold sodium thiomalate and its constituent part, thiomalate, on the virus titres and the lysosomal enzyme activity in peritoneal macrophages of Swiss/A2G mice infected with the avirulent strain of Semliki Forest virus.
    Mehta S; Webb HE
    J Exp Pathol (Oxford); 1990 Jun; 71(3):359-66. PubMed ID: 2164826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
    Dimmock NJ; Kennedy SI
    J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations of reasons for the avirulence of the A7 strain of Semliki Forest virus in adult mice.
    Woodward CG; Marshall ID; Smith H
    Br J Exp Pathol; 1977 Dec; 58(6):616-24. PubMed ID: 607983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of the 3'-nontranslated region and E2 amino acid mutations in the virulence of Semliki Forest virus in mice.
    Santagati MG; Määttä JA; Röyttä M; Salmi AA; Hinkkanen AE
    Virology; 1998 Mar; 243(1):66-77. PubMed ID: 9527916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alphavirus infection on mouse embryos.
    Atkins GJ; Carter J; Sheahan BJ
    Infect Immun; 1982 Dec; 38(3):1285-90. PubMed ID: 6295945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.